Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParkmead Regulatory News (PMG)

Share Price Information for Parkmead (PMG)

Share Price is delayed by 15 minutes
Get Live Data
18.50    -1.00 (-5.13%)
Bid:
18.00
Ask:
19.00
Spread: 1.00 (5.556%)
Market Cap: £20.21m
PMG Live PriceLast checked at - London Stock Exchange

Intraday Parkmead Share Chart

Loan Extension

26 Jul 2019 16:13

RNS Number : 9249G
Parkmead Group (The) PLC
26 July 2019
 

26 July 2019

 

The Parkmead Group plc

("Parkmead", "the Company" or "the Group")

 

 

Extension of Loan, Related Party Transaction

 

 

The Parkmead Group plc is pleased to announce the 24-month extension of the interest-bearing loan to Energy Management Associates Limited ("EMAL") of £2.9 million (the "Loan"). By providing this facility, Parkmead benefits from an exclusive arrangement to join EMAL in new ventures being evaluated by the Company, including inter alia potential opportunities relating to renewable energies. The Loan will continue to bear a fixed interest rate of 2.5 per cent per annum, payable to Parkmead.

 

The entry by the Company into the Loan extension with EMAL, in which Tom Cross is a director and shareholder, is a related party transaction for the purposes of Rule 13 of the AIM Rules. The Directors (other than Tom Cross), having consulted with Arden, consider that such arrangements with EMAL are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

For enquiries please contact:

 

 

The Parkmead Group plc

+44 (0) 1224 622200

Tom Cross (Executive Chairman)

 

Ryan Stroulger (Chief Financial Officer)

 

 

 

 

Arden Partners plc

(Financial Adviser, NOMAD and Corporate Broker to Parkmead)

+44 (0) 20 7614 5900

Ciaran Walsh

 

Maria Gomez de Olea

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEQLFLKDFFBBB
Date   Source Headline
6th Oct 20061:24 pmRNSDirectorate Change
4th Sep 20064:11 pmRNSDirectorate Change
10th Aug 200610:30 amRNSTrading Statement
30th Jun 20063:30 pmRNSCancellation of Share Premium
21st Jun 20064:43 pmRNSDirector/PDMR Shareholding
7th Jun 200612:30 pmRNSDirectorate Change
23rd May 20067:03 amRNSDirector shareholding
15th May 20064:23 pmRNSChange of Name
12th May 200612:13 pmRNSEGM Statement
26th Apr 20061:54 pmRNSCorrection to Announcement
19th Apr 20069:10 amRNSChange of Name
12th Apr 20067:00 amRNSChange of Adviser
5th Apr 20065:25 pmRNSDirector/PDMR Shareholding
5th Apr 200612:00 pmRNSFurther re Sale of Portfolio
31st Mar 20067:02 amRNSInterim Results
2nd Mar 20067:01 amRNSDirectorate Change
1st Mar 200612:14 pmRNSSAR 3 - Interregnum PLC
22nd Feb 200610:52 amRNSSAR 3 - Interregnum Plc
22nd Feb 20067:01 amRNSAcquisition
21st Feb 200612:26 pmRNSResult of EGM
16th Feb 20067:01 amRNSProposed Acquisition
2nd Feb 200610:05 amRNSDirectorate Change
30th Jan 20067:01 amRNSNotice of EGM
13th Jan 200611:03 amRNSDirectorate Change
21st Dec 20057:01 amRNSUpdate
20th Dec 20051:18 pmRNSResult of AGM
13th Dec 20051:24 pmRNSPortfolio Company Funding
24th Nov 20052:57 pmRNSBoard Appointment
27th Oct 20057:01 amRNSFinal Results
13th Oct 200511:55 amRNSNotice of Full Year Results
27th Sep 20057:00 amRNSAcquisition
18th Jul 20052:47 pmRNSDirector/PDMR Shareholding
3rd Jun 20057:00 amRNSITR Red-M IPO
3rd May 20057:00 amRNSAcquisition
27th Apr 20057:01 amRNSSubsidiary Company Merger
16th Mar 20057:00 amRNSAdvises on Sale of Chevin Ltd
14th Mar 20057:00 amRNSRe Agreement
25th Feb 20053:39 pmRNSHolding(s) in Company
24th Feb 20057:30 amRNSInterim Results
21st Feb 20055:15 pmRNSNotice of Results
28th Jan 20054:46 pmRNSHolding(s) in Company
27th Jan 20057:00 amRNSAcquisition & Trading Update
11th Jan 20059:00 amRNSStatement re appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.